RA Capital Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-793,749
Closed -$1.9M 89
2025
Q4
$1.9M Buy
+793,749
New +$2.17M 0.02% 70

Other funds holding HCAT

RA Capital Management's HCAT Position: Q1 2026 in Review

RA Capital Management sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 793,749 shares — an estimated $1.9M sold.

RA Capital Management first reported a position in HCAT in Q4 2025 and held it in 1 quarter. The position peaked at $1.9M in Q4 2025. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • RA Capital Management reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • RA Capital Management sold 793,749 Health Catalyst shares in Q1 2026, an estimated $1.9M.
  • RA Capital Management first reported a position in Health Catalyst in Q4 2025 and held it in 1 quarter.
  • RA Capital Management's Health Catalyst position peaked at $1.9M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on RA Capital Management's 13F filing for Q1 2026, filed 15 May 2026.